OGT 2115 (Standard)
OGT 2115 (Standard) is the analytical standard of OGT 2115 (HY-100898). This product is intended for research and analytical applications. OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 95%
- CAS No.: 853929-59-6
- Formule: C24H16BrFN2O4
- Masse moléculaire:495.30
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-100898
OGT 2115Heparanase Inhibitor -
HY-N2146
Combretastatin A4Microtubule Inhibitor -
HY-10997
IbrutinibBtk Inhibitor -
HY-10964
VadimezanVascular Disrupting Agent -
HY-16141
CilengitideIntegrin Inhibitor -
HY-13426
RoxadustatHIF-PH Inhibitor -
HY-15934
X-GALβ-Galactosidase Substrate -
HY-19332
Kifunensineα-Mannosidases Inhibitor -
HY-P0278
RGDTripeptide -
HY-13734
PX-12Thioredoxin-1 Inhibitor -
HY-12290
Arg-Gly-Asp-SerIntegrin Inhibitor -
HY-N2022
Castanospermineα/β-Glucosidases Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 853929-59-6
-
Masse moléculaire 495.30
-
Formule C24H16BrFN2O4
-
SMILES
O=C(O)CC1=CC=C(OC(C2=CC=C(NC(/C=C/C3=CC=C(Br)C=C3)=O)C(F)=C2)=N4)C4=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. [1]Courtney SM, et al. Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett. 2005 May 2;15(9):2295-9. [Content Brief]
[2]. Li Y, et al. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med. 2013 May;31(5):1234-42. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
OGT 2115 (Standard) Related Classifications
HY-100898R Related Classifications
Powered by Bioz